cellceutix corp (CTIX:OTC BB)

Executive Profile*

Background*

Dr. Emil Frei, III, MD serves as a Physician-in-Chief Emeritus of Dana-Farber Cancer Institute. Dr. Frei is one of the world's leading oncologists, a pioneer of chemotherapy and a leader in medical research, clinical practice and education. His distinguished career includes 40 years in top leadership positions such as Chief of Medicine at National Cancer Institute and an Associate Scientific Director at M.D. Anderson. He served as Physician-in-chief at Dana-Farber Cancer ... Institute from 1973 to 1991. He serves as a Member of Scientific Advisory Board of Celator Pharmaceuticals Inc. and Cellceutix Corporation. He serves as Member of Scintific Advisory Council at Cancer Research Institute, Inc. Dr. Frei served as a Director of Adherex Technologies Inc. until March 2, 2004. He served as Director of Dana-Farber Cancer Institute. He served as a Member of the Scientific and Clinical Advisory Board of Adherex Technologies Inc. A leading clinician-investigator in cancer research, Dr. Frei is the first Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School. He is a Fellow of American Academy of Arts and Sciences since 1999 and a Member of Institute of Medicine since 1997. He received NIH Distinguished Alumni Award in 1990, General Motors Kettering Prize in 1983 and Lasker Award in 1972. Dr. Frei received his MD from Yale University in 1948, conducted his Residency at St. Louis and Washington Universities, and did his Postdoctoral research at the National Cancer Institute.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CTIX:US	$1.98 USD	-0.03

COMPETITOR COMPENSATION